No Data
No Data
Privia Health Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $28
Express News | Privia Health Group Inc : Jefferies Raises Target Price to $26 From $25
Buy-rated Stocks With Passive and Active Net Buying Tailwinds – Citi
We Think You Can Look Beyond Privia Health Group's (NASDAQ:PRVA) Lackluster Earnings
Privia Health Group: Strong Performance and Growth Potential Justifies Buy Rating
No Data
No Data